Australia's Rhinomed rises supply deal for nasal swab product

Rhinomed

18/07/2022 03:53

** Shares of Rhinomed  RNO.AX  rise as much as 14.3% to
A$0.16, their highest level since June 10 
    ** Says it finalised an exclusive supply agreement with
SureScreen Australia to supply Rhinoswabs and Rhinoswab Juniors,
its self-administered nasal swab technology  urn:newsml:reuters.com:*:nASX4cW9dk 
    ** Under deal, Rhinomed will supply a minimum of 10 mln
swabs over a 2 year period
    ** SureScreen to include the products its diagnostic kits
for upper respiratory diseases, including its COVID-19 tests 
    ** Agreement covers distribution of the kits in in
Australia, New Zealand, Singapore and South Pacific markets 
    ** RNO down 54.5% YTD, as of last close 

 (Reporting by Harshita Swaminathan)
 ((Harshita.Swaminathan@thomsonreuters.com))